Medical - Devices
Compare Stocks
5 / 10Stock Comparison
AHCO vs PHG vs MDT vs ISRG vs HOLX
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Medical - Devices
Medical - Instruments & Supplies
Medical - Instruments & Supplies
AHCO vs PHG vs MDT vs ISRG vs HOLX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Devices | Medical - Devices | Medical - Devices | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $1.59B | $25.84B | $99.94B | $161.07B | $16.97B |
| Revenue (TTM) | $2.86B | $17.83B | $35.48B | $10.58B | $4.13B |
| Net Income (TTM) | $-80M | $895M | $4.61B | $2.98B | $544M |
| Gross Margin | 1.8% | 45.2% | 61.9% | 66.3% | 52.8% |
| Operating Margin | 7.2% | 8.0% | 17.9% | 30.5% | 17.5% |
| Forward P/E | 11.7x | 17.5x | 14.1x | 43.8x | 17.2x |
| Total Debt | $1.90B | $8.09B | $28.52B | $303M | $2.63B |
| Cash & Equiv. | $106M | $2.79B | $2.22B | $3.37B | $1.96B |
AHCO vs PHG vs MDT vs ISRG vs HOLX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AdaptHealth Corp. (AHCO) | 100 | 72.5 | -27.5% |
| Koninklijke Philips… (PHG) | 100 | 65.9 | -34.1% |
| Medtronic plc (MDT) | 100 | 79.1 | -20.9% |
| Intuitive Surgical,… (ISRG) | 100 | 234.6 | +134.6% |
| Hologic, Inc. (HOLX) | 100 | 142.6 | +42.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AHCO vs PHG vs MDT vs ISRG vs HOLX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AHCO has the current edge in this matchup, primarily because of its strength in value and momentum.
- Lower P/E (11.7x vs 17.2x)
- +42.4% vs ISRG's -15.4%
Among these 5 stocks, PHG doesn't own a clear edge in any measured category.
MDT is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 36 yrs, beta 0.47, yield 3.6%
- Beta 0.47, yield 3.6%, current ratio 1.85x
- 3.6% yield, 36-year raise streak, vs PHG's 1.5%, (3 stocks pay no dividend)
- 175.8% ROA vs AHCO's -1.8%, ROIC 6.0% vs 4.0%
ISRG ranks third and is worth considering specifically for growth exposure and long-term compounding.
- Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
- 5.5% 10Y total return vs HOLX's 124.3%
- PEG 2.01 vs MDT's 36.00
- 20.5% revenue growth vs PHG's -1.0%
HOLX is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
- Beta 0.41 vs PHG's 1.12, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs PHG's -1.0% | |
| Value | Lower P/E (11.7x vs 17.2x) | |
| Quality / Margins | 28.2% margin vs AHCO's -2.8% | |
| Stability / Safety | Beta 0.41 vs PHG's 1.12, lower leverage | |
| Dividends | 3.6% yield, 36-year raise streak, vs PHG's 1.5%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +42.4% vs ISRG's -15.4% | |
| Efficiency (ROA) | 175.8% ROA vs AHCO's -1.8%, ROIC 6.0% vs 4.0% |
AHCO vs PHG vs MDT vs ISRG vs HOLX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AHCO vs PHG vs MDT vs ISRG vs HOLX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ISRG leads in 3 of 6 categories
AHCO leads 1 • HOLX leads 1 • MDT leads 1 • PHG leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MDT is the larger business by revenue, generating $35.5B annually — 12.4x AHCO's $2.9B. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to AHCO's -2.8%. On growth, AHCO holds the edge at +41.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.9B | $17.8B | $35.5B | $10.6B | $4.1B |
| EBITDAEarnings before interest/tax | $504M | $2.5B | $9.4B | $3.8B | $974M |
| Net IncomeAfter-tax profit | -$80M | $895M | $4.6B | $3.0B | $544M |
| Free Cash FlowCash after capex | $219M | $755M | $5.4B | $2.8B | $1000M |
| Gross MarginGross profit ÷ Revenue | +1.8% | +45.2% | +61.9% | +66.3% | +52.8% |
| Operating MarginEBIT ÷ Revenue | +7.2% | +8.0% | +17.9% | +30.5% | +17.5% |
| Net MarginNet income ÷ Revenue | -2.8% | +5.0% | +13.0% | +28.2% | +13.2% |
| FCF MarginFCF ÷ Revenue | +7.7% | +4.2% | +15.2% | +26.8% | +24.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +41.2% | +1.1% | +8.8% | +23.0% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -140.0% | +2.1% | -11.9% | +18.8% | -9.2% |
Valuation Metrics
AHCO leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 21.6x trailing earnings, MDT trades at a 63% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), ISRG offers better value at 2.65x vs MDT's 36.00x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.6B | $25.8B | $99.9B | $161.1B | $17.0B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $32.1B | $126.2B | $158.0B | $17.6B |
| Trailing P/EPrice ÷ TTM EPS | -22.56x | 24.85x | 21.60x | 57.62x | 30.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.75x | 17.55x | 14.13x | 43.84x | 17.21x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 36.00x | 2.65x | — |
| EV / EBITDAEnterprise value multiple | 5.66x | 10.70x | 14.32x | 43.62x | 17.39x |
| Price / SalesMarket cap ÷ Revenue | 0.49x | 1.23x | 2.98x | 16.00x | 4.14x |
| Price / BookPrice ÷ Book value/share | 1.04x | 2.02x | 2.08x | 9.17x | 3.43x |
| Price / FCFMarket cap ÷ FCF | 7.27x | 24.62x | 19.28x | 64.67x | 18.44x |
Profitability & Efficiency
ISRG leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-5 for AHCO. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to AHCO's 1.25x. On the Piotroski fundamental quality scale (0–9), PHG scores 7/9 vs AHCO's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.1% | +8.2% | +9.4% | +16.9% | +11.0% |
| ROA (TTM)Return on assets | -1.8% | +3.4% | +175.8% | +14.8% | +6.1% |
| ROICReturn on invested capital | +4.0% | +6.4% | +6.0% | +15.0% | +9.4% |
| ROCEReturn on capital employed | +5.0% | +7.1% | +7.5% | +16.5% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 6 | 6 | 7 |
| Debt / EquityFinancial leverage | 1.25x | 0.74x | 0.59x | 0.02x | 0.52x |
| Net DebtTotal debt minus cash | $1.8B | $5.3B | $26.3B | -$3.1B | $667M |
| Cash & Equiv.Liquid assets | $106M | $2.8B | $2.2B | $3.4B | $2.0B |
| Total DebtShort + long-term debt | $1.9B | $8.1B | $28.5B | $303M | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | 0.65x | 4.34x | 9.08x | — | 8.00x |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $4,453 for AHCO. Over the past 12 months, AHCO leads with a +42.4% total return vs ISRG's -15.4%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs HOLX's -2.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.3% | +0.3% | -18.1% | -19.3% | +1.9% |
| 1-Year ReturnPast 12 months | +42.4% | +17.7% | -2.8% | -15.4% | +37.1% |
| 3-Year ReturnCumulative with dividends | -2.8% | +38.8% | -4.2% | +49.6% | -8.5% |
| 5-Year ReturnCumulative with dividends | -55.5% | -42.7% | -27.7% | +58.7% | +15.8% |
| 10-Year ReturnCumulative with dividends | +20.9% | +48.3% | +26.5% | +554.2% | +124.3% |
| CAGR (3Y)Annualised 3-year return | -0.9% | +11.6% | -1.4% | +14.4% | -2.9% |
Risk & Volatility
HOLX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HOLX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than PHG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs MDT's 73.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.83x | 1.12x | 0.47x | 1.02x | 0.41x |
| 52-Week HighHighest price in past year | $13.43 | $33.44 | $106.33 | $603.88 | $76.04 |
| 52-Week LowLowest price in past year | $7.95 | $21.95 | $77.16 | $427.84 | $52.81 |
| % of 52W HighCurrent price vs 52-week peak | +87.3% | +81.2% | +73.3% | +75.1% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 38.2 | 47.7 | 27.3 | 42.4 | 69.1 |
| Avg Volume (50D)Average daily shares traded | 1.5M | 1.0M | 7.8M | 1.8M | 10.0M |
Analyst Outlook
MDT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: AHCO as "Buy", PHG as "Hold", MDT as "Buy", ISRG as "Buy", HOLX as "Hold". Consensus price targets imply 40.5% upside for MDT (target: $110) vs 2.3% for AHCO (target: $12). For income investors, MDT offers the higher dividend yield at 3.57% vs PHG's 1.47%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $12.00 | — | $109.50 | $622.60 | $79.00 |
| # AnalystsCovering analysts | 12 | 22 | 49 | 55 | 42 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% | +3.6% | — | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | 36 | — | — |
| Dividend / ShareAnnual DPS | — | $0.34 | $2.78 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.2% | +1.4% | +4.4% |
ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AHCO leads in 1 (Valuation Metrics).
AHCO vs PHG vs MDT vs ISRG vs HOLX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AHCO or PHG or MDT or ISRG or HOLX a better buy right now?
For growth investors, Intuitive Surgical, Inc.
(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -1. 0% for Koninklijke Philips N. V. (PHG). Medtronic plc (MDT) offers the better valuation at 21. 6x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate AdaptHealth Corp. (AHCO) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AHCO or PHG or MDT or ISRG or HOLX?
On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.
6x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, AdaptHealth Corp. is actually cheaper at 11. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Intuitive Surgical, Inc. wins at 2. 01x versus Medtronic plc's 36. 00x.
03Which is the better long-term investment — AHCO or PHG or MDT or ISRG or HOLX?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +58. 7%, compared to -55. 5% for AdaptHealth Corp. (AHCO). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus AHCO's +20. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AHCO or PHG or MDT or ISRG or HOLX?
By beta (market sensitivity over 5 years), Hologic, Inc.
(HOLX) is the lower-risk stock at 0. 41β versus Koninklijke Philips N. V. 's 1. 12β — meaning PHG is approximately 172% more volatile than HOLX relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 125% for AdaptHealth Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — AHCO or PHG or MDT or ISRG or HOLX?
By revenue growth (latest reported year), Intuitive Surgical, Inc.
(ISRG) is pulling ahead at 20. 5% versus -1. 0% for Koninklijke Philips N. V. (PHG). On earnings-per-share growth, the picture is similar: Koninklijke Philips N. V. grew EPS 224. 0% year-over-year, compared to -185. 2% for AdaptHealth Corp.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AHCO or PHG or MDT or ISRG or HOLX?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -2. 2% for AdaptHealth Corp. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 5. 7% for AHCO. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AHCO or PHG or MDT or ISRG or HOLX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Intuitive Surgical, Inc. (ISRG) is the more undervalued stock at a PEG of 2. 01x versus Medtronic plc's 36. 00x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, AdaptHealth Corp. (AHCO) trades at 11. 7x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 32. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 40. 5% to $109. 50.
08Which pays a better dividend — AHCO or PHG or MDT or ISRG or HOLX?
In this comparison, MDT (3.
6% yield), PHG (1. 5% yield) pay a dividend. AHCO, ISRG, HOLX do not pay a meaningful dividend and should not be held primarily for income.
09Is AHCO or PHG or MDT or ISRG or HOLX better for a retirement portfolio?
For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
47), 3. 6% yield). Both have compounded well over 10 years (MDT: +26. 5%, AHCO: +20. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AHCO and PHG and MDT and ISRG and HOLX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: AHCO is a small-cap quality compounder stock; PHG is a mid-cap quality compounder stock; MDT is a mid-cap income-oriented stock; ISRG is a mid-cap high-growth stock; HOLX is a mid-cap quality compounder stock. PHG, MDT pay a dividend while AHCO, ISRG, HOLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.